Login / Signup
Takaaki Nishimoto
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Phase Iii
Study Protocol
Magnetic Resonance
Combination Therapy
Top Venues
Expert opinion on drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Nobuya Inagaki
,
Takaaki Nishimoto
,
Yoichi Nishiya
,
Daisuke Nitta
Safety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study.
Expert opinion on drug safety
(2022)